Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Migraine, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07022496
What this trial is testing

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

Who this might be right for
MigraineMigraine DiseaseMigraine Headache+2 more
Ain Shams University 120
Post-approval studies (Phase 4)Study completedNCT01248468
What this trial is testing

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

Who this might be right for
Pain, Migraine
Novartis 752
Post-approval studies (Phase 4)Study completedNCT02314351
What this trial is testing

Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

Who this might be right for
Migraine Disorders
Kocaeli University 148
Post-approval studies (Phase 4)Ended earlyNCT01629329
What this trial is testing

Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine

Who this might be right for
Migraine Headaches
Albert Einstein Healthcare Network 93
Large-scale testing (Phase 3)Looking for participantsNCT07674654
What this trial is testing

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

Who this might be right for
Acute Migraine
Kallyope Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT03670810
What this trial is testing

Lasmiditan (LY573144) Over Four Migraine Attacks

Who this might be right for
Migraine
Eli Lilly and Company 1,633
Testing effectiveness (Phase 2)Study completedNCT00384774
What this trial is testing

A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine

Who this might be right for
Migraine
Eli Lilly and Company 130
Large-scale testing (Phase 3)Study completedNCT00897949
What this trial is testing

MK0462 in Treatment of Migraine With Recurrence (MK0462-022)

Who this might be right for
Migraine Headache
Organon and Co 1,473
Post-approval studies (Phase 4)Study completedNCT00364806
What this trial is testing

Prochlorperazine vs Metoclopramide

Who this might be right for
Migraine
Montefiore Medical Center 76
Not applicableStudy completedNCT00126035
What this trial is testing

Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura

Who this might be right for
Migraine With Typical Aura
Profess Medical Consultancy 134
Large-scale testing (Phase 3)WithdrawnNCT01726920
What this trial is testing

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.

Who this might be right for
MigraineHeadache
Ache Laboratorios Farmaceuticos S.A.
Not applicableStudy completedNCT06467370
What this trial is testing

A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

Who this might be right for
Migraine
Pfizer 467
Large-scale testing (Phase 3)Study completedNCT00382993
What this trial is testing

Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Who this might be right for
Migraine Disorders
GlaxoSmithKline 169
Testing effectiveness (Phase 2)Study completedNCT02057315
What this trial is testing

Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine

Who this might be right for
Migraine Headaches
Achelios Therapeutics 48
Testing effectiveness (Phase 2)Looking for participantsNCT07646613
What this trial is testing

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

Who this might be right for
Migraine
Aspeya, Inc. 108
Post-approval studies (Phase 4)Study completedNCT00904098
What this trial is testing

Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine

Who this might be right for
Menstrual Migraine (MM) Headaches
Endo USA Inc., a Keenova Therapeutics Company 192
Early research (Phase 1)Not Yet RecruitingNCT07667621
What this trial is testing

A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department

Who this might be right for
MigraineMigraine DiseaseMigraine in Adults+4 more
University of South Florida 100
Early research (Phase 1)Study completedNCT05707754
What this trial is testing

Sphenopalatine Ganglion Block Study

Who this might be right for
Sphenopalatine Ganglion Nerve Block
Montefiore Medical Center 220
Large-scale testing (Phase 3)Study completedNCT04152083
What this trial is testing

Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

Who this might be right for
Migraine
H. Lundbeck A/S 485
Large-scale testing (Phase 3)Study completedNCT01004263
What this trial is testing

Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)

Who this might be right for
Acute Migraine With or Without Aura in Adolescents
Organon and Co 674
Next Page